Literature DB >> 35067837

Lacticaseibacillus paracasei K56 Attenuates High-Fat Diet-Induced Obesity by Modulating the Gut Microbiota in Mice.

Zhonghua Miao1, Hanying Zheng2, Wei-Hsien Liu3, Ruyue Cheng1, Hui Lan2, Ting Sun3, Wen Zhao3, Jinxing Li1, Xi Shen1, Hongwei Li2, Haotian Feng3, Wei-Lian Hung4, Fang He5.   

Abstract

This study investigated the effects of Lacticaseibacillus paracasei K56 (L. paracasei K56) on body weight, body composition, and glycolipid metabolism in mice with high-fat diet-induced obesity and explored the underlying mechanisms. Male C57BL/6J mice were fed a high-fat diet for 8 weeks to induce obesity; then, the obese mice were gavaged with or without L. paracasei K56 for 10 weeks. The body weight, body composition, fat mass, blood lipid, blood glucose, and hormones of the mice were evaluated. Moreover, the fatty acid synthesis (FAS) and peroxisome proliferator-activated receptor γ (PPAR-γ) expressions in the liver were detected via Western blotting. 16S rRNA gene sequencing was adopted to determine the gut microbiota alterations. The high-fat diet successfully induced obesity, as indicated by the abnormal increase in body weight, visceral fat, fat mass, blood lipids, fasting blood glucose, and insulin-resistance. Moreover, the FAS expression in the liver was significantly increased, whereas the PPAR-γ expression was significantly decreased. The relative abundance of Proteobacteria, Actinobacteria and Patescibacteria was also significantly increased, and that of Verrucomicrobia was significantly decreased. However, these indicators of mice supplemented with L. paracasei K56 were significantly opposite to those of obese mice. The Ruminococcuaceae_UCG-013, Akkermansia, Prevotellaceae_UCG-001, Muribaculum, and Lachnospiraceae_NK4A136 groups were significantly negatively correlated with body weight, blood lipids, and blood glucose-related indicators, whereas Coriobacteriaceae_UCG-002, Enterorhabdus, Raoultibacter, Acinetobacter, Romboutsia, Leuconostoc, and Erysipelatoclostridium were significantly positively correlated with these indicators. L. paracasei K56 might be a promising probiotic strain that could effectively slow down the body weight gain, reduce fat accumulation, alleviate insulin-resistance, and restore pancreatic β-cell function in obese mice by regulating the gut microbiota.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Gut microbiota; High-fat diet; Obesity; Probiotics

Year:  2022        PMID: 35067837     DOI: 10.1007/s12602-022-09911-x

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  18 in total

1.  Antidiabetic effects of selenium-enriched Bifidobacterium longum DD98 in type 2 diabetes model of mice.

Authors:  Dan Zhao; Hui Zhu; Fei Gao; Zhixiang Qian; Wenwei Mao; Yu Yin; Jun Tan; Daijie Chen
Journal:  Food Funct       Date:  2020-07-08       Impact factor: 5.396

2.  The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment.

Authors:  Gouri Ranganathan; Resat Unal; Irina Pokrovskaya; Aiwei Yao-Borengasser; Bounleut Phanavanh; Beata Lecka-Czernik; Neda Rasouli; Philip A Kern
Journal:  J Lipid Res       Date:  2006-08-07       Impact factor: 5.922

Review 3.  Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems.

Authors:  R J Mulders; K C G de Git; E Schéle; S L Dickson; Y Sanz; R A H Adan
Journal:  Obes Rev       Date:  2018-01-23       Impact factor: 9.213

4.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

Review 5.  PPAR gamma gene--a review.

Authors:  C Janani; B D Ranjitha Kumari
Journal:  Diabetes Metab Syndr       Date:  2014-10-13

Review 6.  The human gut microbiota: Metabolism and perspective in obesity.

Authors:  Aline Corado Gomes; Christian Hoffmann; João Felipe Mota
Journal:  Gut Microbes       Date:  2018-05-24

7.  Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes.

Authors:  B Jayashree; Y S Bibin; D Prabhu; C S Shanthirani; K Gokulakrishnan; B S Lakshmi; V Mohan; M Balasubramanyam
Journal:  Mol Cell Biochem       Date:  2013-12-18       Impact factor: 3.396

8.  Environment dominates over host genetics in shaping human gut microbiota.

Authors:  Daphna Rothschild; Omer Weissbrod; Elad Barkan; Alexander Kurilshikov; Tal Korem; David Zeevi; Paul I Costea; Anastasia Godneva; Iris N Kalka; Noam Bar; Smadar Shilo; Dar Lador; Arnau Vich Vila; Niv Zmora; Meirav Pevsner-Fischer; David Israeli; Noa Kosower; Gal Malka; Bat Chen Wolf; Tali Avnit-Sagi; Maya Lotan-Pompan; Adina Weinberger; Zamir Halpern; Shai Carmi; Jingyuan Fu; Cisca Wijmenga; Alexandra Zhernakova; Eran Elinav; Eran Segal
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

9.  Lactobacillus paracasei as a protective factor of obesity induced by an unhealthy diet in children.

Authors:  Ana Cristina Castañeda-Márquez; Cinthya Estefhany Díaz-Benítez; Margarita Bahena-Roman; Guadalupe Evelin Campuzano-Benítez; Marcia Galván-Portillo; Julio César Campuzano-Rincón; Alfredo Lagunas-Martínez; Victor Hugo Bermudez-Morales; Yaneth Citlalli Orbe-Orihuela; Jesús Peralta-Romero; Miguel Cruz; Ana Isabel Burguete-García
Journal:  Obes Res Clin Pract       Date:  2020-06-06       Impact factor: 2.288

Review 10.  Obesity: global epidemiology and pathogenesis.

Authors:  Matthias Blüher
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

View more
  1 in total

1.  Functional components of Chinese rice wine can ameliorate diabetic cardiomyopathy through the modulation of autophagy, apoptosis, gut microbiota, and metabolites.

Authors:  Jinjin Yang; Jiaoying Song; Jiedong Zhou; Hui Lin; Zhuonan Wu; Nan Liu; Wenqing Xie; Hangyuan Guo; Jufang Chi
Journal:  Front Cardiovasc Med       Date:  2022-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.